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OBJECTIVES: This study is aimed at assessing overall and five year survival in 
patients who receive chemotherapy within and after 8 weeks of curative rectal cancer 
resection and to assess the factors causing delay in receiving chemotherapy. 
 
METHODS: This is a historical bidirectional cohort study in which consecutive 
patients who underwent curative rectal cancer surgery in the Department of Surgery 2 
at Christian Medical College Vellore from 1st January 2007 and requiring adjuvant 
chemotherapy were included. The data was collected on the pro formas and through 
telephonic conversations. 
Data was analyzed for survival using Kaplan Meier Curve and Cox proportionate 
Hazard model. Risk factors for delay in chemotherapy will be analyzed using Chi 
square and Independent sample T test and logistic regression. The optimal cut-off for 
delay in chemotherapy was calculated using a receiver-operator characteristic 
(ROC) curve.  
 
RESULTS : 
In our analysis, the majority of patients with stage III rectal cancer had initiated 
adjuvant chemotherapy within 11 weeks of resection. We observed 
that patients with abdominoperineal resection had perineal wound infection and 
dehiscence leading to delayed hospital stay. Mostly delay in chemotherapy initiation 
was due to prolonged hospital stay secondary to post operative complication. 
Comorbidities, age and pathological staging did not cause delay in treatment. Even 
when those factors were taken into account, treatment delay was associated with 
poorer cancer-specific and overall survival. 
However, the initiation of chemotherapy within 8 weeks after surgery 
was not associated with better outcomes. There was no significant difference in 
overall and disease free survival based on timing of adjuvant chemotherapy. 
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